Report cover image

Age-related Macular Degeneration Market Growth, Size, Trends Analysis- By Product, By Molecules, By Type of AMD, By Approval Type, By End User- Regional Outlook, Competitive Strategies and Segment Forecast to 2033

Publisher SPER Market Research Pvt. Ltd.
Published Oct 23, 2024
Length 237 Pages
SKU # SPER19302448

Description

Age-related Macular Degeneration Market Growth, Size, Trends Analysis- By Product, By Molecules, By Type of AMD, By Approval Type, By End User- Regional Outlook, Competitive Strategies and Segment Forecast to 2033


Age-related Macular Degeneration Market Introduction and Overview

According to SPER Market Research, ‘Global Age-related Macular Degenerations Market Size- By Product, By Molecules, By Type of AMD, By Approval Type, By End User – Regional Outlook, Competitive Strategies and Segment Forecast to 2033’ states that the Global Age-related Macular Degenerations Market is estimated to reach USD 26.34 billion by 2033 with a CAGR of 10.97%.

Age-related macular degeneration (AMD) is a degenerative eye disease that mainly affects the elderly. It is characterized by the degeneration of the macula, the central area of the retina that offers sharp, detailed vision. AMD, which can cause blurred or distorted vision and, in its more advanced stages, significant visual loss, can affect routine skills like reading and facial recognition.

The global market for age-related macular degeneration (AMD) is significantly impacted by the COVID-19 pandemic in a number of ways. Patients missed important consultations and follow-up care as a result of delays in routine eye exams and treatments brought on by interruptions in healthcare services. Because COVID-19 was frequently given priority over long-term illnesses like AMD, many persons had an increase in symptoms and a fall in detection rates.

Scope of the report:

Report Metric Details
Market size available for years 2020-2033
Base year considered 2023
Forecast period 2024-2033
Segments covered By Product, By Molecules, By Type of AMD, By Approval Type, By End User
Regions covered North America, Asia-Pacific, Latin America, Middle East & Africa and Europe
Companies Covered Amgen Inc., Bausch Health Companies Inc., Bayer AG, Biogen, F. Hoffmann-La Roche Ltd, Novartis AG, Pfizer Inc., Regeneron Pharmaceuticals Inc., Samsung Bioepis, Others.

Age-related Macular Degenerations Market Segmentation:

By Products: Based on the Products, Global Age-related Macular Degenerations Market is segmented as; Lucentis, Eylea & Eylea HD, Vabysmo, Sofovre, Others.

By Molecules: Based on the Molecules, Global Age-related Macular Degenerations Market is segmented as; Ranibizumab, Aflibercept, Faricimab, Pegcetoplan, Others.

By Type of AMD: Based on the Type of AMD, Global Age-related Macular Degenerations Market is segmented as; Wet AMD, Dry AMD.

By Approval Type: Based on the Approval Type, Global Age-related Macular Degenerations Market is segmented as; Biologic, Biosimilar.

Table of Contents

237 Pages
1. Introduction
1.1. Scope of the report
1.2. Market segment analysis
2. Research Methodology
2.1. Research data source
2.1.1. Secondary Data
2.1.2. Primary Data
2.1.3. SPER’s internal database
2.1.4. Premium insight from KOL’s
2.2. Market size estimation
2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation
3. Executive Summary
4. Market Dynamics
4.1. Driver, Restraint, Opportunity and Challenges analysis
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.1.4. Challenges
4.2. COVID-19 Impacts of the Global Age-related Macular Degeneration Market.
5. Market variable and outlook
5.1. SWOT Analysis
5.1.1. Strengths
5.1.2. Weaknesses
5.1.3. Opportunities
5.1.4. Threats
5.2. PESTEL Analysis
5.2.1. Political Landscape
5.2.2. Economic Landscape
5.2.3. Social Landscape
5.2.4. Technological Landscape
5.2.5. Environmental Landscape
5.2.6. Legal Landscape
5.3. PORTER’s Five Forces
5.3.1. Bargaining power of suppliers
5.3.2. Bargaining power of buyers
5.3.3. Threat of Substitute
5.3.4. Threat of new entrant
5.3.5. Competitive rivalry
5.4. Heat Map Analysis
6. Competitive Landscape
6.1. Global Age-related Macular Degeneration Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Age-related Macular Degeneration Market
7. Global Age-related Macular Degeneration Market, By Products (USD Million) 2020-2033
7.1. Global Age-related Macular Degeneration Market Size, Share and Forecast, By Products, 2020-2026
7.2. Global Age-related Macular Degeneration Market Size, Share and Forecast, By Products, 2027-2033
7.3. Lucentis
7.4. Eylea & Eylea HD
7.5. Vabysmo
7.6. Sofovre
7.7. Others
8. Global Age-related Macular Degeneration Market, By Molecules (USD Million) 2020-2033
8.1. Global Age-related Macular Degeneration Market Size, Share and Forecast, By Molecules, 2020-2026
8.2. Global Age-related Macular Degeneration Market Size, Share and Forecast, By Molecules, 2027-2033
8.3. Ranibizumab
8.4. Aflibercept
8.5. Faricimab
8.6. Pegcetoplan
8.7. Others
9. Global Age-related Macular Degeneration Market, By Type of AMD (USD Million) 2020-2033
9.1. Global Age-related Macular Degeneration Market Size, Share and Forecast, By Type of AMD, 2020-2026
9.2. Global Age-related Macular Degeneration Market Size, Share and Forecast, By Type of AMD, 2027-2033
9.3. Wet AMD
9.4. Dry AMD
10. Global Age-related Macular Degeneration Market, By Approval Type (USD Million) 2020-2033
10.1. Global Age-related Macular Degeneration Market Size, Share and Forecast, By Approval Type, 2020-2026
10.2. Global Age-related Macular Degeneration Market Size, Share and Forecast, By Approval Type, 2027-2033
10.3. Biologic
10.4. Biosimilar
11. Global Age-related Macular Degeneration Market, By End User (USD Million) 2020-2033
11.1. Global Age-related Macular Degeneration Market Size, Share and Forecast, By End User, 2020-2026
11.2. Global Age-related Macular Degeneration Market Size, Share and Forecast, By End User, 2027-2033
11.3. Hospitals
11.4. Specialty Centers
11.5. Long-Term Care Facilities
12. Global Age-related Macular Degeneration Market Forecast, 2020-2033 (USD Million)
12.1. Global Age-related Macular Degeneration Market Size and Market Share
13. Global Age-related Macular Degeneration Market, By Region, 2020-2033 (USD Million)
13.1. Global Age-related Macular Degeneration Market Size and Market Share By Region (2020-2026)
13.2. Global Age-related Macular Degeneration Market Size and Market Share By Region (2027-2033)
13.3. Asia-Pacific
13.3.1. Australia
13.3.2. China
13.3.3. India
13.3.4. Japan
13.3.5. South Korea
13.3.6. Rest of Asia-Pacific
13.4. Europe
13.4.1. France
13.4.2. Germany
13.4.3. Italy
13.4.4. Spain
13.4.5. United Kingdom
13.4.6. Rest of Europe
13.5. Middle East and Africa
13.5.1. Kingdom of Saudi Arabia
13.5.2. United Arab Emirates
13.5.3. Qatar
13.5.4. South Africa
13.5.5. Egypt
13.5.6. Morocco
13.5.7. Nigeria
13.5.8. Rest of Middle-East and Africa
13.6. North America
13.6.1. Canada
13.6.2. Mexico
13.6.3. United States
13.7. Latin America
13.7.1. Argentina
13.7.2. Brazil
13.7.3. Rest of Latin America
14. Company Profile
14.1. Amgen Inc.
14.1.1. Company details
14.1.2. Financial outlook
14.1.3. Product summary
14.1.4. Recent developments
14.2. Bausch Health Companies Inc.
14.2.1. Company details
14.2.2. Financial outlook
14.2.3. Product summary
14.2.4. Recent developments
14.3. Bayer AG
14.3.1. Company details
14.3.2. Financial outlook
14.3.3. Product summary
14.3.4. Recent developments
14.4. Biogen
14.4.1. Company details
14.4.2. Financial outlook
14.4.3. Product summary
14.4.4. Recent developments
14.5. F. Hoffmann-La Roche Ltd
14.5.1. Company details
14.5.2. Financial outlook
14.5.3. Product summary
14.5.4. Recent developments
14.6. Novartis AG
14.6.1. Company details
14.6.2. Financial outlook
14.6.3. Product summary
14.6.4. Recent developments
14.7. Pfizer Inc.
14.7.1. Company details
14.7.2. Financial outlook
14.7.3. Product summary
14.7.4. Recent developments
14.8. Regeneron Pharmaceuticals Inc.
14.8.1. Company details
14.8.2. Financial outlook
14.8.3. Product summary
14.8.4. Recent developments
14.9. Samsung Bioepis
14.9.1. Company details
14.9.2. Financial outlook
14.9.3. Product summary
14.9.4. Recent developments
14.10. Others
15. Conclusion
16. List of Abbreviations
17. Reference Links

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us